Salute e Benessere

Ascentage Pharma Announces Confidential Submission of Draft Registration…

Logo - https://mma.prnewswire.com/media/891219/Ascentage_Pharma_Logo.jpg Logo -https://mma.prnewswire.com/media/891219/Ascentage_Pharma_Logo.jpg View original content: https://www.prnewswire.co.uk/news-releases/ascentage-pharma-announces-confidential-submission-of-draft-registration-statement-for-proposed-initial-public-offering-of-american-depositary-shares-302179764.html
PR Newswire
24/06/2024

DUREX GLOBAL SEX SURVEY REVEALS GREATER SEXUAL SATISFACTION

The 2024 data has unveiled that levels of sexual satisfaction have increased across the world, as 57% of sexually active people stated they are emotionally satisfied and 56% said they were physically satisfied, up 12% and 21%, respectively, since 2006 The 2024 data has unveiled that levels of sexual satisfaction have increased across the world, as 57% of sexually active people stated they are emotionally satisfied and 56% said they were physically satisfied, up 12% and 21%, respectively…
PR Newswire
24/06/2024

KFSHRC Successfully Produces the First Therapeutic T-Cells in the Kingdom

Treatment Costs Reduced by around 80% and Accelerated Access to Treatment RIYADH, Saudi Arabia, June23, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has successfully produced CAR T-cells internally for cancer treatment. This breakthrough has reduced the cost of treatment from 1.3 million SAR to approximately 250,000 SAR per treatment, making it available to patients within 14 days. This achievement overcomes all cost and shipping challenges,...
Nasdaq GlobeNewswire
23/06/2024

Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Molecular…

Juniper Biologics is committed to driving positive change in the pharmaceutical industry on a global scale. Aligned with its mission to deliver transformative therapies through bold scientific innovation, Juniper's collaboration with Caris will enhance access to quality treatments for patient communities in the Middle East and Africa. Juniper continues to pursue impactful partnerships aimed at uplifting communities and individuals, especially in underserved regions where access to advanced…
PR Newswire
23/06/2024

Hisense Enhances UEFA EURO 2024™ Excitement with Immersive Fan Zones

Crafting a scenario-based experience for Hisense's home appliances, Hisense has set up Hisense Fan Zones in Berlin and Munich. These zones feature product displays and interactive games including the Hisense Training Lab, Goalpost Defense, Samba Dance Steps, and Table Football. These fan activities further embody Hisense's determination to 'Never Settle for No.2 Globally'. Crafting a scenario-based experience for Hisense's home appliances, Hisense has set up Hisense Fan Zones…
PR Newswire
23/06/2024

Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and…

The study results demonstrated a superior efficacy of GZR18 Injection than placebo for weight reduction in Chinese obese subjects. After 35 weeks of treatment, the mean weight change from baseline in the GZR18 QW group was -16.5 kg (95% CI: -19.9 kg, -13.1 kg); the placebo-adjusted mean percent weight change from baseline was -18.6% (95% CI: -25.5%, -11.6%). Although it was not a head-to-head study, when compared to the published data on weight reduction of similar products currently available…
PR Newswire
22/06/2024

Casino Group: Agreement with Rocca and Auchan Retail France for the sale of…

Casino Group has signed an agreement with Rocca and Auchan Retail France for the sale of its subsidiary Codim 2 Paris, 22 June 2024Casino Group announces today that it has signed a unilateral purchase agreement for the sale of Codim 2, which operates 4 hypermarkets, 9 supermarkets, 3 cash & carries and 2 drive-throughs in Corsica, with sales of 332 million euros excluding taxes in 2023.As part of the sale, Rocca Group has undertaken to take over all the stores, which will be...
Nasdaq GlobeNewswire
22/06/2024

Description of the Share Repurchase Program Authorised by the Ordinary General…

Pursuant to Article 241-2 of the AMF General Regulations ( Règlement Général de l'Autorité des marchés financiers ), the purpose of this description is to present the objectives and terms of the Company's share repurchase program approved by the Ordinary General Meeting of 20 June 2024, it being specified that the Company does not to date intend to pursue any objective other than to animate the market under a liquidity agreement which has been in place since the listing on Euronext...
Nasdaq GlobeNewswire
21/06/2024

Results of the votes of the Combined Shareholders' General Meeting of June 20…

Daix (France), Long Island City (New York, United States), on June 21, 2024– Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), also known as non-alcoholic steatohepatitis (“NASH”), and other diseases with significant unmet medical needs, today announced the results of the votes of its Combined...
Nasdaq GlobeNewswire
21/06/2024

BioSenic signs a new subscription agreement for a maximum of EUR 2.1M in…

PRESS RELEASE – PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, June 21, 2024 6.00pm CEST –BioSenic(Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases and cell repair, today announces that it has signed a new subscription agreement for a maximum EUR 2.1 million convertible bonds ("CBs") facility, arranged by ABO Securities through its affiliated entity Global Tech Opportunities 15 ("GTO 15").GTO…
Nasdaq GlobeNewswire
21/06/2024

Empty Capsules Market: USD 4.2B by 2029, 6.3% CAGR, Driven by Nutraceuticals &…

Browse in-depth TOC on "Empty Capsules Market" Browse in-depth TOC on "Empty Capsules Market" 356 - Tables48 - Figures333 - Pages Empty Capsules Market Report Highlights: Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=218018190 Market Projection and Growth Drivers The empty capsules market is projected to grow fromUSD 3.1 billionin 2024 toUSD 4.2 billionby 2029, at a CAGR of 6.3%. This growth is driven by...
PR Newswire
21/06/2024

Vivoryon Therapeutics N.V. Reports Outcome of 2024 Annual General Meeting

Vivoryon Therapeutics N.V. Reports Outcomeof 2024 Annual General MeetingHalle (Saale) / Munich, Germany, June 21, 2024– Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon, or the Company ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, held its Annual General Meeting (AGM) today at 1:00 p.m. (CEST). The shareholders approved all items...
Nasdaq GlobeNewswire
21/06/2024

At the SIRM Congress 2024 in Milan, ESAOTE presents the brand-new MyLab™E80, an…

Another step forward in terms of innovation, MyLab™E80 is the first ultrasound system in Esaote's brand-new E series. The 'E' stands for Expertise, referring to a series of devices designed for professionals who deal with more complex clinical cases, where diagnostic certainty and clinical efficiency play a decisive role. Another step forward in terms of innovation,MyLab™E80is the first ultrasound system in Esaote's brand-new E series. The 'E' stands for Expertise, referring to a series...
PR Newswire
21/06/2024

Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO®…

As a symbol of scientific rigor, excellence, and innovation, the "Prix Galien International" awards remarkable recent health innovations available to the public, following an evaluation done by an independent committee of experts. Today this prize exists in fifteen countries, its reputation and influence have made it the most prestigious distinction in the medical field. Through this prize, the jury honors EBVALLO®, thanks to its innovative manufacturing process and mechanism of…
PR Newswire
21/06/2024

Dyspareunia Treatment Market to Hit $1,035.4 million by 2031, at a CAGR of 4.6%…

Market Dynamics: Market Dynamics : The growth of the dyspareunia treatment market is majorly driven by the increasing research and development activities for developing novel therapies to treat dyspareunia. For instance, inAugust 2019, researchers from University ofFlorence,Florence, Italytested the use of fractional carbon dioxide laser therapy for the treatment of provoked vestibulodynia, which is a form of dyspareunia. The results showed that carbon dioxide laser therapy...
PR Newswire
21/06/2024

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.June 21, 2024Company announcement No. 23 1. Details of the person discharging managerial responsibilities/person closely associated...
Nasdaq GlobeNewswire
21/06/2024

Major shareholder announcement

June 21, 2024 Company announcement No. 22Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that Novo Nordisk Fonden has on its own behalf and on behalf of its wholly owned subsidiary Novo Holdings A/S notified Novonesis, that as of yesterday, Novo Nordisk Fonden and Novo Holdings A/S, indirectly and directly, respectively, holds a total of 53,743,600 A-shares (nominally DKK 107,487,200) and 65,672,555 B-shares (nominally DKK 131,345,110) corresponding to...
Nasdaq GlobeNewswire
21/06/2024

Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs…

Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi's Executive CommitteeParis, June 21, 2024. Audrey Duval Derveloy, a seasoned healthcare industry leader and Sanofi France's President, has been named Executive Vice President, Global Head of Corporate Affairs. Audrey will become a member of Sanofi's Executive Committee, reporting into CEO Paul Hudson, and will be based in Paris. Her appointment is effective July 1, 2024.In her new role, Audrey will be...
Nasdaq GlobeNewswire
21/06/2024

Molecular Pharming Market in the North America is Expected to Register the…

Download Free Sample and ToC of the Report:https://www.insightaceanalytic.com/request-sample/1712 Download Free Sample and ToC of the Report:https://www.insightaceanalytic.com/request-sample/1712 Molecular pharming refers to biologics production in plant systems to reduce the cost of microbial systems. Molecular farming is an innovative method for producing molecular medicines, including plasma proteins, enzymes, growth factors, vaccinations, and recombinant antibodies. These medicines...
PR Newswire
21/06/2024

RECKITT'S FIRST GENAI RESULTS DEMONSTRATE CHANGING FACE OF MARKETING DURING…

Beaulieu said: "As expected, GenAI was the most talked-about topic at Cannes - from the formal Festival programme, to fringe events and discussions with partners along the Croisette. As the festival draws to a close, we are proud to share the results of these pilots, as we move to scaling up." Beaulieu said : "As expected, GenAI was the most talked-about topic atCannes- from the formal Festival programme, to fringe events and discussions with partners along the Croisette. As the…
PR Newswire
21/06/2024

Targeted Protein Degradation Market PROTAC Segment is Expected to Highest Growth…

Targeted protein degradation (TPD) seeks to completely remove specific proteins from the cell, rather than merely inhibiting their activity. This approach can potentially provide more effective and sustained treatment outcomes for various diseases by thoroughly eliminating disease-causing proteins. By leveraging the cell's natural degradation pathways, TPD can address issues that traditional therapies cannot, such as drug resistance and incomplete inhibition. Consequently, this innovative…
PR Newswire
21/06/2024

Non-Viral Transfection Reagents Market worth USD 1,157.5 Million to 2031 -…

Transfection, vital for introducing nucleic acids into cells, relies historically on viral vectors but increasingly on non-viral transfection reagents. These chemicals, devoid of viral components, are pivotal in gene therapy, cell-based therapies, and vaccine development due to their safety, ease of use, and adaptability. Transfection, vital for introducing nucleic acids into cells, relies historically on viral vectors but increasingly on non-viral transfection reagents. These chemicals…
PR Newswire
21/06/2024

ISTH announces launch of new global education initiative in factor XI/XIa…

In early 2023, the ISTH organized the multi-disciplinary, international Factor XI/XIa Educational Steering Committee, a group of world-renowned experts led by Jeff Weitz, MD, to survey a sample of the multi-disciplinary target audiences for this education. In early 2023, the ISTH organized the multi-disciplinary, international Factor XI/XIa Educational Steering Committee, a group of world-renowned experts led byJeff Weitz, MD, to survey a sample of the multi-disciplinary target audiences for...
PR Newswire
21/06/2024

Weight Loss Drugs: A Game Changer in the Fight Against Obesity - New InsightAce…

Download Free Sample Report Pages: https://www.insightaceanalytic.com/request-sample/2526 Download Free Sample Report Pages: https://www.insightaceanalytic.com/request-sample/2526 Weight loss drugs work through various mechanisms in the body to promote weight loss, such as reducing appetite, increasing feelings of fullness, decreasing absorption of nutrients, or increasing calorie expenditure. The weight loss drugs market is propelled by the escalating global obesity crisis and...
PR Newswire
21/06/2024
Altri  Comunicati